Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dangerous Interaction Between The Antidepressant Fluvoxamine And The Muscle Relaxant Tizanidine

06.04.2004


Researchers from Finland have found that the antidepressant drug fluvoxamine (brand names Fevarin, Faverin, Luvox etc.) drastically increases the concentrations of tizanidine (Sirdalud, Zanaflex) in blood.



Concomitant use of fluvoxamine and tizanidine results in severe and prolonged decrease in blood pressure and greatly enhanced central nervous system effects. This previously unrecognised interaction can be dangerous, particularly in elderly patients, and the concomitant use of the two agents must be avoided. Both fluvoxamine and tizanidine have been in wide clinical use for more than 10 years.

The concentrations of tizanidine in blood were increased on average 33-fold by fluvoxamine in a carefully controlled study in healthy volunteer subjects. The volunteers ingested the usual 100-mg dose of fluvoxamine or placebo daily for 4 days, and then a single 4-mg dose of tizanidine. The interaction was observed in each of the ten subjects; the smallest increase in tizanidine concentration by fluvoxamine was 14-fold, the greatest increase was 103-fold!


The effects of tizanidine were much stronger during fluvoxamine treatment than during placebo treatment. In particular, the decrease in systolic blood pressure, to the level of 80-mm Hg or even less, was an alarming finding. Such grave hypotension is dangerous, eg in elderly subjects and in patients who have heart problems. Also the central nervous system effects of tizanidine were greatly enhanced by fluvoxamine: all ten subjects were somnolent and dizzy for 3 to 6 hours after tizanidine intake.

Both tizanidine and fluvoxamine are widely used drugs in many countries, including USA. In Finland (population 5 200 000) about 10 000 patients are using tizanidine daily, and about 5000 patients are using fluvoxamine daily. Different types of acute and chronic pain syndromes are common in the patients with depression. Therefore, it is likely that fluvoxamine and tizanidine can be coadministrered frequently, if the risk of the interaction is not recognised by clinicians.

The interaction resulted from inhibition of the liver metabolism of tizanidine by fluvoxamine. Further studies are being carried out to characterise the potential interactions of tizanidine with other drugs.

The study was conducted at the Department of Clinical Pharmacology, University of Helsinki, by an independent group of researchers led by Professor Pertti J Neuvonen, MD, PhD, and Dr. Janne T Backman, MD, PhD. The study was published in the April issue of the scientific journal Clinical Pharmacology & Therapeutics.

Paivi Lehtinen | alfa
Further information:
http://www.helsinki.fi/

More articles from Health and Medicine:

nachricht A new material for regenerative medicine capable to control cell immune response
04.11.2019 | Tomsk Polytechnic University

nachricht New database enhances genomics research collaboration
04.11.2019 | Walter and Eliza Hall Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Memory Effect at Single-Atom Level

An international research group has observed new quantum properties on an artificial giant atom and has now published its results in the high-ranking journal Nature Physics. The quantum system under investigation apparently has a memory - a new finding that could be used to build a quantum computer.

The research group, consisting of German, Swedish and Indian scientists, has investigated an artificial quantum system and found new properties.

Im Focus: Shedding new light on the charging of lithium-ion batteries

Exposing cathodes to light decreases charge time by a factor of two in lithium-ion batteries.

Researchers at the U.S. Department of Energy's (DOE) Argonne National Laboratory have reported a new mechanism to speed up the charging of lithium-ion...

Im Focus: Visible light and nanoparticle catalysts produce desirable bioactive molecules

Simple photochemical method takes advantage of quantum mechanics

Northwestern University chemists have used visible light and extremely tiny nanoparticles to quickly and simply make molecules that are of the same class as...

Im Focus: An amazingly simple recipe for nanometer-sized corundum

Almost everyone uses nanometer-sized alumina these days - this mineral, among others, constitutes the skeleton of modern catalytic converters in cars. Until now, the practical production of nanocorundum with a sufficiently high porosity has not been possible. The situation has changed radically with the presentation of a new method of nanocorundum production, developed as part of a German-Polish cooperation of scientists from Mülheim an der Ruhr and Cracow.

High temperatures and pressures, processes lasting for even dozens of days. Current methods of producing nanometer-sized alumina, a material of significant...

Im Focus: Structured light promises path to faster, more secure communications

Quantum mechanics is embracing patterns of light to create an alphabet that can be leveraged to build a light-based quantum network

Structured light is a fancy way to describe patterns or pictures of light, but deservedly so as it promises future communications that will be both faster and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Smart lasers open up new applications and are the “tool of choice” in digitalization

30.10.2019 | Event News

International Symposium on Functional Materials for Electrolysis, Fuel Cells and Metal-Air Batteries

02.10.2019 | Event News

NEXUS 2020: Relationships Between Architecture and Mathematics

02.10.2019 | Event News

 
Latest News

The secret behind crystals that shrink when heated

04.11.2019 | Physics and Astronomy

Worldwide observations confirm nearby 'lensing' exoplanet

04.11.2019 | Physics and Astronomy

A new material for regenerative medicine capable to control cell immune response

04.11.2019 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>